IXC 0.00% 6.0¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-154

  1. 343 Posts.
    lightbulb Created with Sketch. 23
    I would have thought at least $2 or somewhere around $150M market cap for where we are in terms of trial status. There’s such a large disconnect from where we are and where we should be and this is what I’ve been struggling with for the last 18 months - regardless of the FDA approval.
    what is a miss? It’s the $100M question?!?


 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
0.000(0.00%)
Mkt cap ! $4.509M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $27 445

Buyers (Bids)

No. Vol. Price($)
1 155 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 15689 1
View Market Depth
Last trade - 10.20am 01/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.